Alivus Life Sciences P/B Ratio
Alivus Life Sciences (ALIVUS) P/B ratio is 5.13 (High), book value per share ₹1332.80 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Explore ALIVUS investment value to estimate fundamental worth using multiple valuation models.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
ALIVUS P/B Ratio — Valuation Insights & Book Value Analysis
Alivus Life Sciences price-to-book ratio interpretation, valuation status and historical context — current P/B 5.13 (High). Read ALIVUS dividend payout details for the complete payout history and dividend yield track record.
- Stock appears overvalued with PB of 5.13, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 509.3% above historical average
- Trading at premium to sector average PB of -0.01
Alivus Life Sciences P/B Ratio Historical Trend
ALIVUS annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Alivus Life Sciences stock price NSE.
ALIVUS Historical P/B Ratio — Book Value Per Share & Year-End Price
Alivus Life Sciences annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.07 | ₹1332.8 | ₹1430.80 | ₹3,332 | Moderate |
| 2025 | 0.81 | ₹1126.8 | ₹916.60 | ₹2,817 | Low |
| 2024 | 1.05 | ₹932.8 | ₹983.45 | ₹2,332 | Moderate |
| 2023 | 0.77 | ₹855.2 | ₹657.05 | ₹2,138 | Low |
| 2022 | 0.51 | ₹821.6 | ₹420.15 | ₹2,054 | Low |
ALIVUS vs Healthcare Peers — P/B Ratio Comparison
Alivus Life Sciences P/B 5.13 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |